Biosig announces closing of public offering of common stock

Westport, ct, july 07, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing an innovative biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced the completion of its previously announced underwritten public offering of 2,500,000 shares of its common stock, $0.001 par value per share, at a price to the public of $4.00 per share. the gross proceeds to biosig from this offering were $10 million, before deducting the underwriting discounts and commissions and estimated offering expenses payable by biosig.
BSGM Ratings Summary
BSGM Quant Ranking